Peter Macfarlane: h-index, Total Citations, and Citation Map
Peter Macfarlane's h-index is 97 (320 i10-index, 59,338+ total citations across 733+ publications) according to Google Scholar as of August 2026. Peter Macfarlane is affiliated with Emeritus Professor of Electrocardiology.
Peter Macfarlane is a researcher affiliated with Emeritus Professor of Electrocardiology, specializing in Automated ECG analysis. Their work has been cited 59,338 times. This profile visualizes their global influence, highlighting strong citation networks in United States.
Peter Macfarlane's Citation Metrics
Bibliometric impact based on 733 indexed publications.
- H-Index
- 97
- i10-Index
- 320
- Total Citations
- 59,338
- Citing Countries
- 76
As of August 2026.
Peter Macfarlane has an h-index of 97 and 59,338 total citations across 733 publications, with research cited by institutions in 76 countries.
Download Exports (PNG, CSV, Poster)
Free Viewing Peter Macfarlane's citation map is always free. Pay once to download poster, PNG, and CSV files for offline use or your visa packet.
Global Impact Map
Visualizing the geographic distribution of institutions that have cited your work.
Starting…
Pins will appear here as institutions are resolved — no need to refresh.
Prevention of coronary heart disease with pravastatin in men with hypercholesterolemia
199510,080
Top Citing Countries
Top Citing Institutions
Visa Evidence Package
Views and exports tuned for EB-1A, O-1A, and EB-2 NIW petitions. Sustained acclaim, geographic reach, and independent-citation filtering are the strongest evidence categories immigration adjudicators look for.
Significant Contributions
Auto-detected research lines — a seminal paper and the follow-up work building on it. Review and edit before using in a petition. Each Free PDF opens in a new tab — EB-1A organises this into the structure USCIS applies to Criterion 5 of 8 CFR § 204.5(h)(3)(v); EB-1B re-frames it under § 204.5(i)(3) (outstanding researcher); NIW presents it under prong 2 of Matter of Dhanasar.
The researcher established the efficacy of pravastatin in preventing coronary heart disease among men with hypercholesterolemia, a seminal finding published in the New England Journal of Medicine.
The researcher conducted a landmark randomized controlled trial evaluating pravastatin efficacy in elderly patients at vascular risk, establishing critical evidence for statin therapy in this demographic.
The researcher established C-reactive protein as a critical predictor of coronary heart disease and diabetes within metabolic syndrome frameworks, significantly advancing cardiovascular risk stratification.
Citation trend (last 10 years)Click to expand
Citation Trend (Last 10 Years)
Related Guides
Learn how to use citation maps for your research and visa applications.
About Peter Macfarlane's research
Peter Macfarlane is a researcher in Automated ECG analysis at Emeritus Professor of Electrocardiology. Their work has been cited 59,338 times across 733 publications (h-index 97), according to Google Scholar.
Their most-cited work, “Prevention of coronary heart disease with pravastatin in men with hypercholesterolemia” (1995), has accumulated 10,080 citations. Other influential works include “Pravastatin in elderly individuals at risk of vascular disease (PROSPER): a randomised controlled trial” (2002) with 4,869 citations and “Statins and risk of incident diabetes: a collaborative meta-analysis of randomised statin trials” (2010) with 3,568 citations.
Citations of Peter Macfarlane's research come primarily from United States, China and United Kingdom, reflecting international research impact across 5+ countries. The interactive citation map above shows the full geographic distribution of the institutions citing this work.
